Under the terms of the deal, the company will gain the exclusive global license to develop, manufacture, and commercialize Chinese drugmaker Hansoh Pharmaceutical Group Co.s HS-10535, an experimental oral drug that targets the receptors for GLP-1, Merck said in a statement Wednesday
It works by affecting brain chemicals like dopamine and norepinephrine, which can help reduce appetite
The current trial demonstrated the potentially useful role of GLP-1 receptor agonists to enhance weight-loss maintenance in the management of severe adolescent obesity, although we did not demonstrate a statistically significant result, the researchers wrote
J.ShaivitzA.et al
Gastrointestinal bloating, on the other hand, is isolated to the GI system and commonly feels like pressure or excessive fullness, sometimes accompanied by visible abdominal distention
Frequently Asked Questions People can start losing weight with Semaglutide in the first week